Purchase Order N0017317P1264
Award Date 5/5/17
Potential Completion Date 8/3/17
Potential Value $5.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Office of Naval Research awarded a $16,302 firm fixed-price purchase order to Illumina, Inc. for reagent kits on September 26, 2013, with completion targeted for October 26, 2013. The contract, issued without a set-aside designation, will be performed in San Diego, California. Illumina is a biotechnology company specializing in genetic sequencing and genomic analysis technologies, providing DNA and RNA sequencing instruments, reagents, consumables, and bioinformatics software to federal...
- <p>The Office of Naval Research awarded a purchase order to Illumina, Inc. valued at $31,592.90 on August 17, 2017. Place of performance is San Diego, California. The order is for firm fixed-price commercial biotechnology equipment or services, with ultimate completion scheduled for September 15, 2017. No small business set-aside was applied.</p>
- The Office of Naval Research awarded a $15,965 firm fixed-price purchase order to Illumina, Inc. for MiSeq Annual Service on July 10, 2015, with completion scheduled for July 9, 2016. The contract, which did not utilize a set-aside designation, covers maintenance and support services for Illumina's MiSeq DNA sequencing instrument at the contractor's San Diego, California location. Illumina is a leading biotechnology company specializing in genetic sequencing and genomic analysis technologies,...
- The Office of Naval Research awarded a $15,000 firm fixed-price purchase order to Illumina, Inc. on July 10, 2014, for the MiSeq Silver Contract, with completion targeted for July 9, 2015. The contract, which carries no set-aside designation, will be performed in San Diego, California. Illumina, a biotechnology company specializing in genetic sequencing and genomic analysis technologies, will deliver products or services supporting the Navy's research initiatives. The MiSeq platform is one of...
- Illumina, Inc., a San Diego-based biotechnology company specializing in genetic sequencing and genomic analysis technologies, received a $91.6K firm fixed-price delivery order from the Plains Area office, a civilian agency, for Illumina Reagents and laboratory equipment, consumables, and services. The contract was awarded on September 16, 2022, with an ultimate completion date of September 13, 2023, with performance to be conducted in San Diego, California. This delivery order does not carry a...
- This is a firm fixed price delivery order awarded by the Office of Administrative Services Procurement Management Branch, a civilian agency, to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $98,056.80 order is for Illumina kits with no set-aside designation. Illumina has a history of providing sequencing systems and consumables to support genomic research and diagnostics across various federal agencies including NIH, CDC, USDA, and VA. This...
- Illumina, Inc., a San Diego-based biotechnology company specializing in genomic sequencing and analysis technologies, was awarded a Purchase Order contract by the Office of Administrative Services Procurement Management Branch on April 7, 2015, with a ceiling value of $29,529.80 and an ultimate completion date of April 30, 2016. This Firm Fixed Price contract, which carries no set-aside designation, is to be performed in Athens, Georgia. As a leading provider of DNA and RNA sequencing...
- This is a $114,751.84 firm fixed price delivery order awarded by the Bureau of Medicine and Surgery, a component of the Department of the Navy, to Illumina, Inc. for the provision of various nucleic acid sequencing reagents and positive controls for Illumina sequencing instruments. The order is part of a larger $3.3 million Indefinite Delivery Contract held by Illumina with the Navy Bureau of Medicine and Surgery to support nucleic acid sequencing needs, including for characterizing biological...
- <p>The Office of Naval Research awarded a purchase order to Illumina, Inc. valued at $31,278.96 on February 18, 2021, for Illumina Chemicals with firm fixed-price pricing and no set-aside designation. Place of performance is Washington, DC 20375. The order was issued under a Special Notice opportunity posted February 9, 2021, with a due date of February 11, 2021, and ultimate completion date of March 22, 2021.</p>
- This federal contract award was made by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a for-profit biotechnology company headquartered in San Diego, California. The $17,258.05 firm fixed-price delivery order contract has an ultimate completion date of October 9, 2025. Illumina is a manufacturer of advanced DNA and RNA sequencing instruments, reagents, and bioinformatics software. This contract does not have a set-aside designation, reflecting Illumina's specialized...